Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 6;28(5):255-256.
doi: 10.14744/AnatolJCardiol.2024.4224. Online ahead of print.

Factors Influencing the Risk of No-Reflow Development

Yücel Kanal  1
Affiliations

Factors Influencing the Risk of No-Reflow Development

Yücel Kanal. Anatol J Cardiol. .
No abstract available

PubMed Disclaimer

References

    1. Çelik İE, Öztürk S, Yarlıoğlu M,et al. The association between atherogenic index of plasma and no-reflow phenomenon in acute coronary syndrome. Anatol J Cardiol. 2023;27(12):712 719. ( 10.14744/AnatolJCardiol.2023.3381) - DOI - PMC - PubMed
    1. Rezkalla SH, Kloner RA. Coronary no-reflow phenomenon. Curr Treat Options Cardiovasc Med. 2005;7(1):75 80. ( 10.1007/s11936-005-0008-0) - DOI - PubMed
    1. Kanal Y, Balci KG, Yaman NM, Yakut Í, Ozbay MB, Maden O. The relationship between CHA2DS2-VASc score and reperfusion success in elective percutaneous saphenous vein graft interventions. Int J Cardiovasc Sci. 2023;36. ( 10.36660/ijcs.20230027) - DOI
    1. Maden O, Çakmak Karaaslan Ö, Kanal Y, et al. Association of CHA2DS2-VASc score with thrombus burden in patients with acute myocardial infarction undergoing SVG-PCI. Herz. 2022;47(5):456 464. ( 10.1007/s00059-021-05070-x) - DOI - PubMed
    1. Kaul S. The “no reflow” phenomenon following acute myocardial infarction: mechanisms and treatment options. J Cardiol. 2014;64(2):77 85. ( 10.1016/j.jjcc.2014.03.008) - DOI - PubMed

LinkOut - more resources